Paul Bassett, Clinical Trials Manager, MMRC
One of the highlights of Paul Bassett’s
helps to facilitate
[enrollment] before 70% of non-MMRC
career in pharmaceutical drug
concept
sites could even get opened. It’s just
development is an award he received
development
tremendous in terms of bringing these
for creating a new dosing protocol for
and proposal
medicines to patients who are out there
Phase 1 clinical research sites, which
submission,
waiting for them. There’s no greater
resulted in an annual savings of $325
manage budgets
sense of urgency than knowing that
million. He was also awarded funding
and regulatory aspects,
there are patients out there with an
to develop a smartphone app currently
and drive to the startup phase — fast.
unmet need, or that these clinical trials
being used to determine patient
eligibility in real time. Clearly, Paul is
well qualified to be the “boots on the
ground” in his role as Clinical Trials
Manager for the Multiple Myeloma
Research Consortium (MMRC). Paul
“We focus on accelerating the startup
of clinical trials and getting them done
faster than anyone else,” he says. “We’re
could actually help them extend their
lives or improve their quality of life.
There are not enough hours in the day.”
pretty aggressive about clinical trials.
One trial opened 111 days faster
than non-MMRC sites and closed
SAVE THE DATE
S AT U R D AY, O C T O B E R 2 4 , 2 0 1 5
MMRF ANNUAL FALL GALA
TO B E N E F I T T H E M U LT I P L E M Y E LO M A R E S E A RC H F O U N DAT I O N
H YAT T R E G E N C Y G R E E N W I C H
OLD GREENWICH, CT
www.themmrf.org/FallGala